The prognostic value of S6K2 and/or 4EBP1 in IGFR/HER2 positive tumours could be confirmed in two additional public datasets, and was also independent of the strong proliferation marker E2F1 (Fig 2). The gene discussed is IGF1R; the disease is neoplasm.